BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10451029)

  • 1. Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice.
    Arab S; Rutka J; Lingwood C
    Oncol Res; 1999; 11(1):33-9. PubMed ID: 10451029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.
    Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul M
    Clin Cancer Res; 2001 Mar; 7(3):634-40. PubMed ID: 11297259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.
    Roth W; Isenmann S; Naumann U; Kügler S; Bähr M; Dichgans J; Ashkenazi A; Weller M
    Biochem Biophys Res Commun; 1999 Nov; 265(2):479-83. PubMed ID: 10558893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice.
    Ishitoya S; Kurazono H; Nishiyama H; Nakamura E; Kamoto T; Habuchi T; Terai A; Ogawa O; Yamamoto S
    J Urol; 2004 Mar; 171(3):1309-13. PubMed ID: 14767339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells.
    Arab S; Murakami M; Dirks P; Boyd B; Hubbard SL; Lingwood CA; Rutka JT
    J Neurooncol; 1998 Nov; 40(2):137-50. PubMed ID: 9892096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.
    Narla RK; Liu XP; Myers DE; Uckun FM
    Clin Cancer Res; 1998 Jun; 4(6):1405-14. PubMed ID: 9626456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of malignant meningioma with verotoxin.
    Salhia B; Rutka JT; Lingwood C; Nutikka A; Van Furth WR
    Neoplasia; 2002; 4(4):304-11. PubMed ID: 12082546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic.
    Arab S; Lingwood CA
    J Cell Physiol; 1998 Dec; 177(4):646-60. PubMed ID: 10092217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM; Lingwood CA
    Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological inhibitory effects of the Chinese herb danggui on brain astrocytoma.
    Lee WH; Jin JS; Tsai WC; Chen YT; Chang WL; Yao CW; Sheu LF; Chen A
    Pathobiology; 2006; 73(3):141-8. PubMed ID: 17085958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
    Leggas M; Stewart CF; Woo MH; Fouladi M; Cheshire PJ; Peterson JK; Friedman HS; Billups C; Houghton PJ
    Clin Cancer Res; 2002 Sep; 8(9):3000-7. PubMed ID: 12231547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
    Kilic T; Alberta JA; Zdunek PR; Acar M; Iannarelli P; O'Reilly T; Buchdunger E; Black PM; Stiles CD
    Cancer Res; 2000 Sep; 60(18):5143-50. PubMed ID: 11016641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
    Gupta B; Torchilin VP
    Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.
    Kunkel P; Ulbricht U; Bohlen P; Brockmann MA; Fillbrandt R; Stavrou D; Westphal M; Lamszus K
    Cancer Res; 2001 Sep; 61(18):6624-8. PubMed ID: 11559524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
    Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy resistance of glioblastoma stem cells.
    Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
    Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.
    Arab S; Russel E; Chapman WB; Rosen B; Lingwood CA
    Oncol Res; 1997; 9(10):553-63. PubMed ID: 9507533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.